Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up: Prefer In Af Registry.

Brüggenjürgen, B; Schliephacke, T; Darius, H; De, Caterina R; Le, Heuzey J Y; Reimitz, P E; Schilling, R J; Schwertfeger, M; Zamorano, J L; Kirchhof, P

Brüggenjürgen, B; Schliephacke, T; Darius, H; De, Caterina R; Le, Heuzey J Y; Reimitz, P E; Schilling, R J; Schwertfeger, M; Zamorano, J L; Kirchhof, P.

Afiliación

Brüggenjürgen B; Steinbeis University Berlin (SHB), Berlin, Germany.
Schliephacke T; Daiichi Sankyo Europe GmbH, Munich, Germany.
Darius H; Vivantes Hospital Neukölln, Berlin, Germany.
De CR; G. d'Annunzio University, Chieti, Italy.
Le HJ; Hôpital Européen Georges Pompidou, Université René Descartes, Paris, France.
Reimitz PE; Daiichi Sankyo Europe GmbH, Munich, Germany.
Schilling RJ; Barts and St Thomas Hospital, London, UK.
Schwertfeger M; Daiichi Sankyo Europe GmbH, Munich, Germany.
Zamorano JL; University Hospital Ramón y Cajal, Madrid, Spain.
Kirchhof P; University of Birmingham Centre for Cardiovascular Sciences and SWBH NHS Trust, Birmingham, UK.

Value Health ; 17(7): A493, 2014 Nov.

Article en En | MEDLINE | ID: mdl-27201472

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google